A recent study demonstrated that rapid phosphorylation of SphK2 by epidermal growth factor (EGF) or phorbol 12-myristate 13-acetate (PMA), a known tumor-promoting agent, resulted in an increase in kinase activity and thus enhanced EGF-induced chemotaxis of human breast cancer cells [219]. This evidence concerns the gene EGF and breast carcinoma.